These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10176448)

  • 1. Combating silent PPOs.
    Belt JE; Ryan JB
    Healthc Financ Manage; 1998 Feb; 52(2):44-5. PubMed ID: 10176448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenging silent PPO discounts.
    Speisman A; Hachenburg M
    Healthc Financ Manage; 2006 Nov; 60(11):102-6. PubMed ID: 17094284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cost analysis: judging a PPO's feasibility.
    Eastaugh SR
    Healthc Financ Manage; 1986 May; 40(5):44-51. PubMed ID: 10276170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Special report. Doing business with managed care plans: making the best of it.
    Bolinger R
    Part B News; 1989 Jun; 3(6):suppl 1-6. PubMed ID: 10313588
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective contracting in California: experience in the second year.
    Johns L; Anderson MD; Derzon RA
    Inquiry; 1985; 22(4):335-47. PubMed ID: 2934329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for physician contracting with alternative delivery systems.
    Kucera WR; Marren JP
    J Med Pract Manage; 1987; 2(3):200-6. PubMed ID: 10281433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent PPOs are not PPOs.
    Elden DL
    Health Care Innov; 1995; 5(4):6, 38-9. PubMed ID: 10184544
    [No Abstract]   [Full Text] [Related]  

  • 8. HMOs are reduced to being prepaid indemnity health insurers.
    Johnson DE
    Health Care Strateg Manage; 2001 Jun; 19(6):19, 1. PubMed ID: 11409094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When is it time to walk away from an HMO/PPO contract? How to analyze the financial impact of alternative delivery systems on hospitals.
    Turner BN; Valentine ST
    Healthc Forum J; 1989; 32(2):13-6. PubMed ID: 10292195
    [No Abstract]   [Full Text] [Related]  

  • 10. Achieving incremental volume increases.
    Belt JE
    Healthc Financ Manage; 1997 Apr; 51(4):43, 45-7. PubMed ID: 10166277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managed care pricing strategies shifting.
    Hospitals; 1985 Aug; 59(16):85-6. PubMed ID: 4018770
    [No Abstract]   [Full Text] [Related]  

  • 12. Nursing PPOs for corporate clients.
    Collins BA
    Nurs Econ; 1987; 5(2):86-9. PubMed ID: 3645313
    [No Abstract]   [Full Text] [Related]  

  • 13. Questioning assumptions about preferred provider arrangements.
    Boland P
    Inquiry; 1985; 22(2):132-41. PubMed ID: 3159669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preferred provider organizations: options for Medicare.
    Bachman SS; McGuire TG; Pomeranz D; Tompkins CP; Porell FW; Wallack SS
    Inquiry; 1989; 26(1):24-34. PubMed ID: 2523342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of injecting price competition into the hospital market: the case of preferred provider organizations.
    Dranove D; Satterthwaite M; Sindelar J
    Inquiry; 1986; 23(4):419-31. PubMed ID: 2947862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control costs through contract examination.
    Tintari M; Greenberg N; Pishko L
    Patient Acc; 1986 Oct; 9(10):2. PubMed ID: 10278727
    [No Abstract]   [Full Text] [Related]  

  • 17. Exposing the "silent" PPO.
    Scott RS
    Adm Radiol; 1995 Aug; 14(8):48, 51. PubMed ID: 10151507
    [No Abstract]   [Full Text] [Related]  

  • 18. Interstudy report shows providers give larger discounts to national PPOs.
    Health Care Strateg Manage; 2001 Mar; 19(3):9-10. PubMed ID: 11258243
    [No Abstract]   [Full Text] [Related]  

  • 19. Silent PPOs: the stealth discounting of provider reimbursement.
    Marks JW
    J Med Pract Manage; 2005; 21(2):85-8. PubMed ID: 16302436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent or nonexistent? PPOs seen as getting illicit discounts are targeted by bill.
    Gardner J
    Mod Healthc; 1998 Aug; 28(35):36. PubMed ID: 10182795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.